ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus.
Adult
Betacoronavirus
COVID-19
Coronavirus Infections
/ prevention & control
Diabetes, Gestational
/ diagnosis
Endocrinology
/ methods
Female
Humans
Obstetrics
/ methods
Pandemics
/ prevention & control
Pneumonia, Viral
/ prevention & control
Practice Guidelines as Topic
Pregnancy
Pregnancy Complications, Infectious
/ prevention & control
Prenatal Care
/ methods
SARS-CoV-2
Journal
European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
20
04
2020
accepted:
26
05
2020
pubmed:
27
5
2020
medline:
2
7
2020
entrez:
27
5
2020
Statut:
ppublish
Résumé
The COVID-19 pandemic has required rapid transformation and adaptation of healthcare services. Women with gestational diabetes mellitus (GDM) are one of the largest high-risk groups accessing antenatal care. In reformulating the care offered to those with GDM, there is a need to balance the sometimes competing requirement of lowering the risk of direct viral transmission against the potential adverse impact of service changes. We suggest pragmatic options for screening of GDM in a pandemic setting based on blood tests, and risk calculators applied to underlying risk factors. Alternative models for antenatal care provision for women with GDM, including targeting high-risk groups, early lifestyle interventions and remote monitoring are provided. Testing options and their timing for postpartum screening in women who had GDM are also considered. Our suggestions are only applicable in a pandemic scenario, and usual guidelines and care pathways should be re-implemented as soon as possible and appropriate.
Identifiants
pubmed: 32454456
doi: 10.1530/EJE-20-0401
pii: EJE-20-0401
pmc: PMC7938017
doi:
pii:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
G49-G56Subventions
Organisme : Medical Research Council
ID : MR/J000094/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N006232/1
Pays : United Kingdom
Références
N Engl J Med. 2008 May 8;358(19):1991-2002
pubmed: 18463375
Diabetes Care. 2016 Jun;39(6):982-7
pubmed: 27208333
J Clin Med. 2020 Mar 18;9(3):
pubmed: 32197374
Diabetes Care. 2018 Jul;41(7):1346-1361
pubmed: 29934478
BMC Pregnancy Childbirth. 2018 Dec 14;18(1):494
pubmed: 30547769
Int J Environ Res Public Health. 2020 Apr 27;17(9):
pubmed: 32349442
PLoS Med. 2018 Oct 29;15(10):e1002681
pubmed: 30372451
Cochrane Database Syst Rev. 2017 Aug 23;8:CD007122
pubmed: 28832911
JMIR Mhealth Uhealth. 2018 Mar 20;6(3):e71
pubmed: 29559428
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31
pubmed: 31862745
Endocrine. 2016 Dec;54(3):714-722
pubmed: 27601018
Diabet Med. 2013 Apr;30(4):452-6
pubmed: 23323841
Diabetes Care. 2010 Mar;33(3):676-82
pubmed: 20190296
Pharmacoecon Open. 2020 Sep;4(3):499-510
pubmed: 32026397
Curr Diab Rep. 2016 Jan;16(1):7
pubmed: 26742932
Diabetes Care. 2018 Jul;41(7):e111-e112
pubmed: 29748432
BMJ Open. 2019 Jan 4;9(1):e023293
pubmed: 30612109
BMJ. 2017 Jul 19;358:j3119
pubmed: 28724518
Diabetes Care. 2020 Jan;43(Suppl 1):S183-S192
pubmed: 31862757
Rev Obstet Gynecol. 2011;4(1):22-7
pubmed: 21629495
Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:197-202
pubmed: 27129745
J Clin Med. 2018 Feb 20;7(2):
pubmed: 29461483
Diabetes. 1979 Dec;28(12):1039-57
pubmed: 510803
Diabetologia. 2017 Mar;60(3):399-405
pubmed: 27913848
Diabetologia. 2016 Mar;59(3):445-52
pubmed: 26589686
BMJ. 2016 Aug 30;354:i4338
pubmed: 27576867
Diabetes Care. 2007 May;30(5):1314-9
pubmed: 17290037
Aust N Z J Obstet Gynaecol. 2011 Dec;51(6):499-504
pubmed: 21951203
Diabetes Ther. 2018 Dec;9(6):2305-2313
pubmed: 30284689